The China-Africa Business Council (CABC) China-Africa Health Industry Alliance has taken swift and substantive action to support Africa’s fight against COVID-19, delivering essential diagnostic equipment and supplies to strengthen continental and national public health systems. Working closely with its member enterprises, CABC provided targeted donations to help African partners enhance testing capacity, accelerate early detection, and protect frontline workers—advancing both pandemic response and long-term sustainable health systems.
In 2020, CABC delivered two key contributions officially acknowledged by African health authorities. The organization donated 12,000 disposable sample collectors to the Africa Centres for Disease Control and Prevention (Africa CDC), supporting continent-wide pandemic coordination.
Separately, CABC and member firm Sansure Biotech provided one IPONATIC diagnostic instrument and 500 testing kits to the Ethiopian Public Health Institute (EPHI), significantly boosting Ethiopia’s ability to conduct independent COVID-19 testing. Both donations were confirmed through formal signed receipt notes from Africa CDC Director Dr. John Nkengasong and EPHI Director General Dr. Ebba Abate.
Besides, King Deer Company President Mr. Zheng Haisheng, who is also vice chairman of CABC, donated a pharmaceutical factory valued at 200 million yuan (about 28 million U.S. dollars) to the Madagascar government. King Deer ventured into Madagascar in 1997, just four years before China's WTO accession, becoming one of the first Chinese enterprises to establish a cashmere production base in Africa. The firm's successful localization strategy is reflected in a dramatic shift in workforce composition: the company employs 3,200 local workers and only 31 Chinese technical personnel.
These efforts reflect CABC’s commitment to international solidarity, health security, and sustainable development across Africa. By strengthening local diagnostic capacity and supporting evidence-based pandemic response, CABC helped improve health resilience while advancing UN Sustainable Development Goal 3 (Good Health and Wellbeing) and the One Health approach linking human health, environmental safety, and cross-border disease prevention.
